Next Generation Wound Care Products for the World
LifeScience PLUS is a leading, advanced wound care technology company committed to developing and marketing innovative total wound care solutions: hemostasis (bleeding control), sealant, moist dressing, contamination prevention, and fast tissue growth generation. Our patented best-in-class flagship product BloodSTOP® iX Advanced Hemostat and WoundHEAL® is revolutionary technology for both acute and chronic wound care. BloodSTOP® iX Was Awarded For “Best In Category for Hemostat and Wound Healing” on Burn Wound Donor Site by 51st American Burn Association 2019.
Applications for this technology are numerous. Our primary focus is for medical professionals during surgical procedures, including burn and trauma surgeries, treatment of ulcer wounds, pre-hospital and emergency trauma wound care.
Trauma Care
Burn Surgery
Medical/Surgical
Dentistry & Oral Surgery
Sports Medicine
Consumer
Our Products
The BloodSTOP® product family is a leading new generation of wound care products for surgery, emergency trauma care, paramedics, ulcers, and dental wounds. This advanced technology provides power to control bleeding and power to heal.
BloodSTOP® and BloodSTOP® iX are biocompatible, non-irritating, natural plant based materials. Upon meeting blood or body exudates, they adhere to a wound, initiate blood coagulation, stop bleeding fast, and form a protective membrane layer which creates an optimal environment for fast wound healing. Their water solubility allows for removal by rinsing, without disruption of a clotted surface.
LSP Online Store Launch, Including Surgical Masks!
LifeScience PLUS is pleased to announce the launch of the BloodSTOP online store. You can order all of LSP’s revolutionary wound care products from this site faster and easier than before, with additional methods of payment, including all credit cards. Go to...
School Reopening: Are You Ready?
Schools in United States have been closed for over two months since the outbreak of COVID-19. According to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, it might be time to consider reopening schools based on the level of...
Slow Acceptance of Masks in US
COVID-19 pandemic has much increased the masks presence in public. However, some people still refuse to wear a facemask because it is not a culture norm in the United States, and they feel strongly about their personal liberty, according to SFChronicle. Infectious...
Future Events
Dr. Stathis Poulakidas, MD, FACS
Division Chief of Burn Surgery
Cook County Health Burn Center, Chicago, IL
View Full Testimonial
A 9 year old female with unknown genetic disorders presented after multiple treatments of open wounds of the scalp, abdomen and leg. Attempts at using Sulfamylon, Aquacel AG, Silvadene, and Gentian Violet yielded no improvement.
The most worrisome component of the patent’s care was the weekly cleanings in which the patient bled over 500cc’s, requiring transfusion of 2 units of blood at every OR visit.
With the introduction of BloodSTOP® iX, wound debridments were able to be done limiting blood loss to <200cc’s and only requiring one unit or a partial unit of blood.
With good wound care, decrease of infections secondary to IV antibiotics and improved nutritional status, wounds started healing. Without the use of BloodSTOP® iX, any type of debridement and cleaning of these wounds would not have been possible at one OR sitting.
To conclude, all prior treatments failed to stop the bleeding for the patient’s head, chest and legs. However, her situation was controlled with BloodSTOP® iX.